TY - JOUR
T1 - Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data
Y1 - 2023
PY - 2023
DA - 2023
N1 - doi:2023.22720
T2 - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JF - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JO - EJMI
SP - 153
EP - 161
VL - 7
IS - 2
SN - 
M3 - doi:2023.22720
UR - https://dx.doi.org/10.14744/ejmi.2023.22720
Y2 - 2023
ER -